Fibrinogen apheresis in the treatment of peripheral arterial disease

Blood Purification

Volumn 25, Issue 5-6, 2008, Pages 404-410

  Ramunni, A ^a   Brescia, P ^a   Quaranta, D ^a   Plantamura, M ^a   Ria, R ^a   Coratelli, P ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Adhesion molecules; Fibrinogen; Fibrinogen apheresis; Laser Doppler flowmetry; Peripheral arterial disease

Indexed keywords

BLOOD CLOTTING FACTOR 8; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROCOAGULANT; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ANKLE BRACHIAL INDEX; APHERESIS; ARTERY DISEASE; ARTERY ENDOTHELIUM; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIALYSIS EQUIPMENT AND SUPPLIES; FEMALE; HEMODYNAMICS; HUMAN; LABORATORY TEST; LASER DOPPLER FLOWMETRY; LEG; MALE; MICROCIRCULATION; PAIN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN BLOOD FLOW; STATISTICAL SIGNIFICANCE; WALKING;

AGED; AGED, 80 AND OVER; BLOOD COMPONENT REMOVAL; ENDOTHELIUM, VASCULAR; EXERCISE TOLERANCE; FEMALE; FIBRINOGEN; HEMODYNAMICS; HUMANS; LOWER EXTREMITY; MALE; MICROCIRCULATION; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; SKIN; TREATMENT OUTCOME; WALKING;

EID: 38849095961     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109101     Document Type: Article

References (33)

1. Dieter RS, Chu WW, Pacanowski JP Jr, Mc-Bridge PE, Tanke TE: The significance of lower extremity peripheral arterial disease. Clin Cardiol 2002;25:3-10.
2. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR;TASC II Working Group: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33:S1-S75.
3. Strandness DJ, Sumner D: Hemodynamics for Surgeons. New York, Grune & Stratton, 1975, pp 278-281.
4. Otto C, Richter WO, Schwand P: Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertrigliceridemia: evaluation by selective depletion of low-density lipoproteins or fibrinogen. Metabolism 2000;49:810-813.
5. Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL: Clinical, hemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J 1973;4:576-581.
6. Stuart J, George AJ, Davies AJ, Aukland A, Hurlow RA: Haematological stress syndrome in atherosclerosis. J Clin Pathol 1981;34:464-467.
7. Woodburn KR, Lowe GD, Rumley A, Love J, Pollock JG: Relation of hemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease. Int Angiol 1995;14:346-352.
8. Leng GC, Papacosta O, Whincup P, Wannamethee G, Walker M, Ebrahim S, Nicolaides AN, Dhanjil S, Griffin M, Belcaro G, Rumley A, Lowe GD: Femoral atherosclerosis in an older British population: prevalence and risk factors. Atherosclerosis 2000;152:167-174.
9. Blatter W, Straub PW, Jeanneret C, Horak GS: Effect of low fibrinogen concentrations on the rheology of human blood in vitro. Am J Physiol 1979;236:H447-H450.
10. Dupont PA, Sirs JA: The relationship of plasma fibrinogen, erythrocyte flexibility and blood viscosity. Thromb Haemost 1977;38:660-667.
11. Koll RA, Klinkmann J, Richter WO: Rheo-Sorb: a specific adsorber for fibrinogen elimination in clinical situations with impaired rheology. Artif Organs 2002;26:145-151.
12. Fontaine R, Kim M, Kieny R: Die chirurgische Behandlung der peripheren Durchblutungsstörungen. Helv Chir Acta 1954;21:499-533.
13. McDermott MM, Liu K, Guralnik JM: The ankle brachial index independently predicts walking velocity and walking endurance in peripheral arterial disease. J Am Geriatr Soc 1998;46:1355-1362.
14. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T: Single LDL-apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997;95:76-82.
15. Igarashi K, Tsuji M, Nishimura M, Horimoto M: Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia. J Clin Apher 2004;19:11-16.
16. Mellwig K, Baller D, Gleichmann U, Moll D, Betker S, Weise R, Notohamiprodjo G: Improvement of coronary vasodilatation capacity through single LDL apheresis. Atherosclerosis 1998;139:173-178.
17. Suckfull M: Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 2002;360:1811-1817.
18. Ramunni A, Giancipoli G, Guerriero S, Lapenna L, Saracino A, Saliani MT, Capurso A, Sborgia C, Coratelli P: LDL-apheresis accelerates the recovery of nonarteritic acute anterior ischemic optic neuropathy. Ther Apher Dial 2005;9:53-58.
19. Ramunni A, Ranieri G, Giancipoli G, Guerriero S, Ria R, Saliani MT, Sborgia L, Ranieri P, Coratelli P: Is the efficacy of LDL apheresis in ischemic optic neuropathy linked to a reduction in endothelial activation markers? Blood Purif 2006;24:405-412.
20. Ernst E, Resch KL: Fibrinogen as a cardiovascular risk factor. Ann Intern Med 1993;118:956-963.
21. Danesh J, Lewington S, Thompson SG, et al; Fibrinogen Studies Collaboration: Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005;294:1799-1809.
22. Folsom AR, Conlan MG, Davis CE, Wu KK;Atherosclerosis Risk in Communities (ARIC) Study Investigators: Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Ann Epidemiol 1992;2:481-494.
23. DiMinno G, Silver MJ, Cerbone AM, Rainone A, Postiglione A, Mancini M: Increased fibrinogen binding to platelets from patients with familial hypercholesterolemia. Arteriosclerosis 1986;6:203-211.
24. Koenig W, Sund M, Ernst E, Mraz W, Hombach V, Keil U: Association between rheology and components of lipoproteins in human blood: results from the MONICA project. Circulation 1992;85:2197-2204.
25. Pulawski E, Mellwig KP, Brinkmann T, Kleesiek K, Horstkotte D: Influence of single lowdensity lipoprotein apheresis on the adhesion molecules soluble vascular cellular adhesion molecule-1, soluble intercellular adhesion molecule-1 and P-selectin. Ther Apher 2002;6:229-233.
26. Empen K, Otto C, Brodi UC, Parhofer KG: The effects of three different LDL-apheresis methods on the plasma concentrations of Eselectin, VCAM-1 and ICAM-1. J Clin Apher 2002;17:38-43.
27. Jaeger BR, Goehring P, Schirmer J, Uhrig S, Kreuzer E, Reichart B, Seidel D: Consistent lowering of clotting factors for the treatment of acute cardiovascular syndromes and hypercoagulability: a different pathophysiological approach. Ther Apher 2001;5:252-259.
28. Wang Y, Blessing F, Walli AK, Uberfuhr P, Fraunberger P, Seidel D: Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins - reduction of circulating proinflammatory and procoagulatory markers. Atherosclerosis 2004;175:145-150.
29. Yates CJ, Berent A, Andrews V, Dormandy JA: Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudication. Lancet 1979;2:166-168.
30. Schuff-Werner P, Schutz E, Seyde WC, Eisenhauer TH, Janning G, Armstrong VW, Seidel D: Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Eur J Clin Invest 1989;19:30-37.
31. Klingel R, Erdtracht B, Gauss V, Piazolo A, Mausfeld-Lafdhiya P, Diehm C: Rheopheresis in patients with critical limb ischemia - results of an open label prospective pilot trial. Ther Apher Dial 2005;9:473-481.
32. Stewart J, Kohen A, Brouder D, Rahim F, Adler S, Garrick R, Goligorky MS: Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. Am J Physiol Heart Circ Physiol 2004;287:H2687-H2696.
33. Kruger A, Stewart J, Sahiyani R, O'Riordan E, Thompson C, Adler S, Garrick R, Vallance P, Goligorsky MS: Laser Doppler flowmetry detection of endothelial dysfunction in endstage renal disease patients: correlation with cardiovascular risk. Kidney Int 2006;70:157-164.